Milestone Pharmaceuticals Inc. 是一間生物製藥公司,專注於心血管藥物的開發及商業化。公司總部位於加拿大蒙特利爾。
財務指標
營業收入
2026-06-30
$559K
2026-03-31
$238K
2025-12-31
$1.54M
2025-09-30
$0
營業支出
2026-06-30
$26.15M
2026-03-31
$23.94M
2025-12-31
$18.8M
2025-09-30
$11.87M
淨利潤
2026-06-30
-$28.61M
2026-03-31
-$26.06M
2025-12-31
-$17.4M
2025-09-30
-$11.92M
淨利潤率
2026-06-30
-5.11K%
2026-03-31
-10.95K%
2025-12-31
-1.12K%
2025-09-30
--
每股收益
2026-06-30
$-0.21
2026-03-31
$-0.20
2025-12-31
$-0.15
2025-09-30
$-0.12
息稅折舊攤銷前利潤
2026-06-30
-$23.83M
2026-03-31
-$21.98M
2025-12-31
-$16.39M
2025-09-30
-$11M
有效稅率
2026-06-30
--
2026-03-31
0.41%
2025-12-31
0.53%
2025-09-30
0.6%
項目
2026-06-30
2026-03-31
2025-12-31
2025-09-30
營業收入
$559K
$238K
$1.54M
$0
營業支出
$26.15M
$23.94M
$18.8M
$11.87M
淨利潤
-$28.61M
-$26.06M
-$17.4M
-$11.92M
淨利潤率
-5.11K%
-10.95K%
-1.12K%
--
每股收益
$-0.21
$-0.20
$-0.15
$-0.12
息稅折舊攤銷前利潤
-$23.83M
-$21.98M
-$16.39M
-$11M
有效稅率
--
0.41%
0.53%
0.6%
常見問題
MIST is the ticker symbol for Milestone Scientific Inc., a company that develops and markets computer-controlled injection technologies for medical and dental applications. Its systems are designed to deliver precise drug delivery, aiming to improve patient comfort and procedural accuracy. The company generates revenue through device sales and related consumables, serving healthcare providers such as dentists and anesthesiologists. Its product portfolio includes the STA Single Tooth Anesthesia System and the CompuFlo Epidural System. MIST is listed on the NYSE American exchange.
The latest price of MIST stock is displayed in real time on the stock detail page above. This figure changes throughout the trading day based on supply and demand, so it is best to refer to the live quote for the most current information. The page also typically shows other relevant data such as daily price range, volume, and previous close. For the most up-to-date MIST stock price, please check the quote section on this page.
MIST stock price fluctuates due to a variety of factors, including company-specific news such as product approvals, clinical trial results, or financial performance. Broader market conditions, sector trends, and investor sentiment can also influence the price. Additionally, changes in the economic outlook, interest rates, or competitive landscape may affect demand for the stock. Since MIST is a small-cap company, its price can be more sensitive to news and trading volume compared to larger, more established firms.
Because MIST may not have consistent positive earnings, traditional valuation metrics like the price-to-earnings (P/E) ratio might not be meaningful. Instead, investors often look at price-to-sales (P/S) and price-to-book (P/B) ratios, as well as enterprise value relative to revenue. Comparing these metrics to industry peers and historical averages can provide context. However, valuation should be considered alongside growth prospects, profitability, and risk factors. For current valuation metrics, refer to the data on this page.
Trading activity for MIST can vary. It is listed on the NYSE American, which typically has lower trading volumes than major exchanges like the NYSE or Nasdaq. Investors should check the average daily volume and current volume, which are displayed on the stock detail page. Lower liquidity can lead to wider bid-ask spreads and greater price volatility. For the most accurate assessment of trading activity, review the volume data provided on this page.
Key risks for MIST include its small-cap status, which can result in higher volatility and lower liquidity. The company operates in the medical device sector, so it faces regulatory hurdles, lengthy approval processes, and reimbursement challenges. It may also have a history of losses and depend on a limited number of products for revenue. Competition from larger, well-established medical device companies is another risk. Additionally, intellectual property protection and successful commercialization of new products are critical to its future performance.